IDH1 R132H

IDH1 R132H


Isocitrate Dehydrogenase 1 (IDH1) is a soluble, cytosolic enzyme involved in the TCA metabolic cycle. The most notable mutation in this enzyme, R132H, is clinically indicated in the majority of astrocytomas and oligodendroglial tumours, with the mutation being associated with more favourable prognosis and increased survival in those patients. IDH1 R132H is also useful in the differential diagnosis between anaplastic glioma and glioblastoma.

SKU: N/A Category:
Image Variation SKU Price Quantity Add To Cart
IDH1-R132H-IHC132-Astrocytoma 0.1ml IHC132-100 648.00
Add to cart
IDH1-R132H-IHC132-Astrocytoma 1ml IHC132-1 2,834.00
Add to cart
IDH1-R132H-IHC132-Astrocytoma Positive Control 3 slides IHC132-PC 1,328.00
Add to cart


CE-IVD registered and supplied as a concentrate.   


Clone IHC132
Source Mouse Monoclonal
Positive Control Astrocytoma
Dilution Range 1:100 – 1:200


  1. Cui D, et al. Int J Biochem Cell Biol. 2016;71:72-81.
  2. Balss J, et al. Acta Neuropathol. 2008; 116:597-602.
  3. Capper D, et al. Brain Pathol. 2010; 20:245-54.
  4. Camelo-Piragua S, et al. Acta Neuropathol. 2010; 119:509-11.

Additional information


0.1ml, 1ml, Positive Control 3 slides


Instructions for Use

Safety Data Sheet

Price Quote